Susunod

Auto-play

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

23 Mga view • 07/30/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play